NOVARTIS AG - SPONSORED ADR (NVS)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
132M
Holdings value Q3 2024
$15.2B
Value change Q3 2024
-$629M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
1284
Number of buys Q3 2024
482
Number of sells Q3 2024
-552
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 132M $15.2B -$629M $115.02 1,290
2024 Q2 138M $14.7B -$144M $106.46 1,296
2024 Q1 140M $13.6B -$108M $96.73 1,233
2023 Q4 141M $14.2B -$811M $100.97 1,254
2023 Q3 148M $15.1B -$2.43M $101.86 1,205
2023 Q2 148M $14.9B -$1.63B $100.91 1,182
2023 Q1 162M $14.9B -$603M $92.00 1,156
2022 Q4 171M $15.5B -$871M $90.72 1,172
2022 Q3 180M $13.6B -$1.52B $76.01 1,070
2022 Q2 199M $16.9B -$492M $84.53 1,123
2022 Q1 208M $18.3B -$256M $87.75 1,121
2021 Q4 211M $18.4B -$794M $87.47 1,135
2021 Q3 220M $18B +$259M $81.78 1,069
2021 Q2 217M $19.8B -$97M $91.24 1,112
2021 Q1 218M $18.6B -$804M $85.48 1,127
2020 Q4 228M $21.5B +$231M $94.43 1,169
2020 Q3 226M $19.7B -$1B $86.96 1,111
2020 Q2 238M $20.7B -$820M $87.34 1,125
2020 Q1 247M $20.4B -$921M $82.45 1,124
2019 Q4 257M $24.4B +$1.32B $94.69 1,162
2019 Q3 244M $21.2B -$1.14B $86.90 1,087
2019 Q2 257M $23.5B -$1.43B $91.31 1,091
2019 Q1 274M $26.2B +$86M $96.14 1,124
2018 Q4 273M $23.4B +$1.02B $85.81 1,080
2018 Q3 260M $22.4B +$468M $86.16 1,014
2018 Q2 255M $19.3B +$304M $75.54 977
2018 Q1 256M $20.7B +$333M $80.85 1,004
2017 Q4 250M $21B -$565M $83.96 1,000
2017 Q3 259M $22.2B -$114M $85.85 930
2017 Q2 260M $21.7B -$332M $83.47 911
2017 Q1 253M $18.8B +$1.2B $74.27 901
2016 Q4 237M $17.2B +$775M $72.84 895
2016 Q3 237M $18.7B +$46M $78.96 869
2016 Q2 235M $19.4B -$248M $82.51 872
2016 Q1 226M $16.4B +$176M $72.44 862
2015 Q4 236M $20.3B -$2.2M $86.04 923
2015 Q3 234M $21.5B +$238M $91.92 920
2015 Q2 235M $23.1B +$111M $98.34 939
2015 Q1 234M $23.1B -$44.1M $98.61 932
2014 Q4 235M $21.7B +$102M $92.66 907
2014 Q3 230M $21.7B -$346M $94.13 867
2014 Q2 236M $21.3B -$161M $90.53 839
2014 Q1 237M $20.2B -$336M $85.02 826